Named as a key player in 396 of our reports, across 33 regions and countries.
[1] ClinicalTrials.gov, Studies led by Allergan or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Our reports that name Allergan as a key player, by category and place.
Markets where they are a key player. Each opens the market's statistics for every place we cover.
None of their markets match.
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Named as key players in the same markets as Allergan (number of shared markets).
Galderma S.A.4 shared markets
Novartis AG4 shared markets
Pfizer Inc.4 shared markets
Bausch Health Companies Inc.3 shared markets
Bayer AG3 shared markets
Croma Pharma3 shared markets
Merck & Co., Inc.3 shared markets
Merz Aesthetics3 shared markets
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
1 active study led by Allergan, of 517 in all
Source: ClinicalTrials.gov, Studies with Allergan (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
7 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
12 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
33 recalls since 2015 (9 for medicines, 24 for devices)
Source: openFDA, FDA enforcement reports (recalls) naming the firm, since 2015. Retrieved 13 Nov 2026.
Annual reports and other filings with the US Securities and Exchange Commission.
Source: SEC EDGAR, Company filings, CIK 1578845.
Studies Allergan leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Allergan or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
The topics of the markets Allergan is in.
Stories on the topics Allergan works in.
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
Collagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
Read
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Read